What is the Non-Clinical Chemical Biology PhD programme? 

The CRUK Convergence Science Centre (CSC) is partnering with The Institute of Chemical Biology (ICB) EPSRC Centre for Doctoral Training to provide a 4 year PhD studentship. Projects will involve the development of novel molecular tools and technologies in Chemical Biology to study molecular interactions that address an unmet need in cancer.

ICB logo

What are the benefits of undertaking a PhD with Convergence Science Centre? 

  1. World class training 

Students will follow the four-year version of the non-clinical PhD training programme. You will be trained by world leading experts in cancer biology, engineering and physical sciences at Imperial and the ICR. This will enable you to acquire a broad skill set and learn the language of multiple disciplines. 

 

  1. High-quality research outputs 

With a range of outputs spanning research publications, presentations at relevant conferences, the PhD will provide you the grounding for your future success as a convergence scientist. 

 

  1. Convergence Science Centre Bespoke Training programme  

The scientific landscape is constantly evolving, with disciplines merging into novel entities. To navigate interdisciplinary research, our students are required to develop flexibility by learning to integrate diverse skill sets. To support them, we've designed a training programme aimed at developing skills required to work across the boundaries of different disciplines.   

 

What's available? 

Successful candidates will receive a £23,000 tax-free student stipend (living allowance) per year for 4 years plus payment of university tuition fees at Home status. 

 

Eligibility 

The standard Convergence Science Centre PhD programme and studentship academic eligibility criteria are: 

 

  • A first or upper second-class honours degree (or equivalent from a non-UK university) in a relevant subject. 

  • A master’s degree in a relevant subject 

  • Appropriate English language skills. 

 

More information coming soon.